
VRRX Therapeutics Private Limited
About VRRX Therapeutics Private Limited
Data last updated:
VRRX Therapeutics Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the diversified business activities segment of the business services sector. It was incorporated on 19 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2017PTC120084.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.38 Cr. It is led by directors including Indira Jagan and Ravi Kiran Deevi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 20 (Old 9) Parthasarathy Gardens Alwarpet, Chennai, Tamil Nadu, India – 600018.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.44 Lakh, a decline of 75% compared to the previous year. For the same year it recorded a net loss of ₹14.61 Lakh (net margin -94.6%) and EBITDA of -₹10.39 Lakh (EBITDA margin -67.3%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 31% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of VRRX Therapeutics
Contact details
VRRX Therapeutics Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered Address20 (Old 9) Parthasarathy Gardens Alwarpet, Chennai, Tamil Nadu, India – 600018
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of VRRX Therapeutics is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of VRRX Therapeutics Private Limited, buy the company report.
Financials of VRRX Therapeutics Private Limited
FY 2025 filings availableVRRX Therapeutics Private Limited reported revenue of ₹15.44 Lakh (down 75% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 75% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 31%. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -67.3% | ||||
| Net Profit Margin | -94.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VRRX Therapeutics Private Limited, buy the company report.
Board of directors of VRRX Therapeutics Private Limited
VRRX Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indira Jagan Also directs: Shisan Technologies Private Limited | Director | 19 Dec 2017 | 8 Years 11 Months | Current |
| Ravi Kiran Deevi | Director | 01 Feb 2020 | 6 Years 9 Months | Current |
| Ishaan C Jagan | Director | 19 Dec 2017 | 8 Years 11 Months | Current |
Peer comparison
VRRX Therapeutics Private Limited is compared with the 7 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atpiy Technologies Private Limited | ₹15.45 Lakh (FY 2022) | Hyderabad, Telangana, India | ||||
| Firstricoz Private Limited | ₹15.45 Lakh (FY 2024) | -31.0% | Delhi, India | |||
| NK Crafts & Designs Private Limited | ₹15.44 Lakh (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| VRRX Therapeutics Private Limitedthis company | ₹15.44 Lakh (FY 2024) | -₹14.61 Lakh | -94.6% | -75.0% | Chennai, Tamil Nadu, India | |
| Deltaworld Technologies Private Limited | ₹15.44 Lakh (FY 2025) | -13.0% | Thanjavur, Tamil Nadu, India | |||
| Euphotic Labs Private Limited | ₹15.43 Lakh (FY 2024) | 52.0% | Bangalore, Karnataka, India | |||
| Cashntech Private Limited | ₹15.43 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Paksa Ideas Private Limited | ₹15.43 Lakh (FY 2024) | -51.0% | Kolkata, West Bengal, India |
To see the full peer comparison of VRRX Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving VRRX Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VRRX Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for VRRX Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
VRRX Therapeutics Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Ravi Kiran Deevi was appointed as Director on 01 Feb 2020.
Frequently asked questions
VRRX Therapeutics is an active private limited company based in Chennai, Tamil Nadu, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 19 December 2017 (9+ years old) and is registered under CIN U74999TN2017PTC120084.
VRRX Therapeutics has 3 current directors:
- Indira Jagan - Director
- Ravi Kiran Deevi - Director
- Ishaan C Jagan - Director
The latest financial statements of VRRX Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of VRRX Therapeutics is U74999TN2017PTC120084. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VRRX Therapeutics was incorporated on 19 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of VRRX Therapeutics by revenue are Atpiy Technologies Private Limited, Firstricoz Private Limited, NK Crafts & Designs Private Limited, Deltaworld Technologies Private Limited, Euphotic Labs Private Limited and 2 more, all in the same principal business activity (other professional, scientific and technical activities).
Ravi Kiran Deevi was appointed as Director on 01 Feb 2020. Indira Jagan was appointed as Director on 19 Dec 2017. Ishaan C Jagan was appointed as Director on 19 Dec 2017.
Yes, VRRX Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of VRRX Therapeutics is at 20 Old 9 Parthasarathy Gardens Alwarpet, Chennai, Tamil Nadu, India – 600018.
VRRX Therapeutics operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of VRRX Therapeutics is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.

